Psychiatric Medication, Practically

Forgot Your Antidepressant on a Trip: What the Week Will Feel Like

Save

A week-long gap without your antidepressant can trigger discontinuation symptoms, with severity depending on your medication's half-life. This article covers what to expect, real options for getting medication while traveling, and how restarting typically works once you're home, without needing to guess at any of it.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What will this week without your antidepressant actually feel like?

A week without your antidepressant is enough time, for many medications, to produce discontinuation symptoms -- dizziness, flu-like aches, irritability, or emotional swings are the commonly reported pattern, generally starting within the first few days of the gap 1. How intense it gets varies by person and drug, but a full week is well within the window where symptoms are expected to show up rather than a borderline case. It's uncomfortable, but it's also a recognized, temporary pattern rather than a medical mystery, described broadly across reviews of psychotropic medication discontinuation 2.

Does it matter which medication you're on?

Yes, significantly. Medications with a shorter half-life -- venlafaxine, desvenlafaxine, paroxetine among them -- tend to produce faster and more noticeable symptoms within days of a gap, while longer half-life medications like fluoxetine act more like a built-in taper and often produce a later, gentler onset even across a full week away 3. Why some antidepressants are harder to stop than others covers this half-life pattern in more depth. If you know which category your medication falls into, you have a reasonable sense of what this week is likely to feel like before it even starts.

What are your options for getting medication while still traveling?

Worth trying quickly: calling your regular pharmacy to ask about an early refill or transfer to a pharmacy near you while traveling, checking whether your insurance plan has a "vacation override" policy for exactly this situation, and calling your prescriber's office to explain what happened and ask what they recommend. Many pharmacies and prescribers have handled this exact scenario before -- it's common enough that asking directly, rather than assuming nothing can be done, is worth the phone call, even if you're not sure your specific plan or pharmacy offers this option.

What happens when you get home and restart?

This article can't tell you how to restart -- whether to resume at your usual dose immediately or ease back in is a decision for your prescriber, based on how long the gap was and your specific medication. What's useful to know going in is that restarting after a week-long gap is a normal, manageable conversation prescribers have regularly; it isn't something you need to figure out or apologize for on your own. Many people worry they've done something wrong by missing this much medication, but a travel gap like this is common enough that prescribers have a routine way of handling it.

Building a trip kit so this doesn't happen again

A missed week away from home is exactly the kind of gap that a little advance planning prevents. A working system for staying ahead of psych med refills covers building in a buffer specifically for travel, and knowing how soon symptoms tend to start for your specific medication ahead of time means you're not caught off guard mid-trip. If this happens again, calling your prescriber's office as soon as you realize -- not waiting until you're back -- gets you the most useful guidance, whether that's a bridge prescription or simply reassurance.

Common questions

Discontinuation symptoms from a week-long gap are generally described as temporary and resolving once the medication is restarted, though how uncomfortable that week feels varies by medication and person.

Often yes -- calling your regular pharmacy about a transfer or early refill, and checking your insurance for a vacation override policy, are worth trying before assuming nothing can be done.

No -- decisions about how to restart, including dose and timing, belong with your prescriber, who can advise based on your specific medication and how long the gap lasted.

Shorter half-life medications like venlafaxine, desvenlafaxine, or paroxetine tend to produce faster, more noticeable symptoms within days, while longer half-life medications like fluoxetine tend to produce a later, gentler onset.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

If the week away turns into something more severe

  • Symptoms that are severe rather than uncomfortable
  • Confusion, fainting, or chest symptoms
  • A significant mood shift that feels unsafe
  • Thoughts of self-harm or suicide

A week-long medication gap affects people differently based on the specific drug and individual factors; this describes general patterns, not a prediction for your case. This is general information, not medical advice. If you are in crisis, call or text 988 (Suicide & Crisis Lifeline), free and available 24/7.

References

  1. 1.Davies J, Read J (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive Behaviors. doi:10.1016/j.addbeh.2018.08.027antidepressant-withdrawalwithdrawal-durationguidelines
  2. 2.Cosci F, Chouinard G (2020). Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Psychotherapy and Psychosomatics. doi:10.1159/000506868withdrawal-syndromepsychotropic-discontinuationprotracted-withdrawal
  3. 3.Henssler J, Heinz A, Brandt L, Bschor T (2019). Antidepressant Withdrawal and Rebound Phenomena: A Systematic Review. Deutsches Arzteblatt International. doi:10.3238/arztebl.2019.0355antidepressant-withdrawalrebounddiscontinuation-syndrome

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy